BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 17375261)

  • 1. Purine and pyrimidine receptors.
    Burnstock G
    Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine and purinergic receptors.
    Burnstock G
    Brain Neurosci Adv; 2018; 2():2398212818817494. PubMed ID: 32166165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
    Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
    J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinoceptors in the nervous system.
    Fredholm BB
    Pharmacol Toxicol; 1995 Apr; 76(4):228-39. PubMed ID: 7617551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nucleotide receptors--structure and function, history and perspectives].
    Barańska J
    Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling by extracellular nucleotides in anterior pituitary cells.
    Stojilkovic SS; Koshimizu T
    Trends Endocrinol Metab; 2001 Jul; 12(5):218-25. PubMed ID: 11397647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypes.
    Kennedy C
    Purinergic Signal; 2021 Mar; 17(1):9-23. PubMed ID: 33527235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of purinergic signaling in cardiovascular diseases.
    Ralevic V; Burnstock G
    Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introductory overview of purinergic signalling.
    Burnstock G
    Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of single-chain heterodimeric G-protein-coupled receptors for adenosine and dopamine.
    Kamiya T; Saitoh O; Nakata H
    Cell Struct Funct; 2005 Feb; 29(5-6):139-45. PubMed ID: 15840945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine and pyrimidine (P2) receptors as drug targets.
    Jacobson KA; Jarvis MF; Williams M
    J Med Chem; 2002 Sep; 45(19):4057-93. PubMed ID: 12213051
    [No Abstract]   [Full Text] [Related]  

  • 17. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
    Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
    Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2-pyrimidinergic receptors and their ligands.
    Müller CE
    Curr Pharm Des; 2002; 8(26):2353-69. PubMed ID: 12369950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.